[HTML][HTML] Detection of minimal residual disease using ctDNA in lung cancer: current evidence and future directions
YK Chae, MS Oh - Journal of thoracic oncology, 2019 - Elsevier
Advances in DNA sequencing methods have significantly expanded the potential clinical
applications of analyzing circulating tumor DNA (ctDNA). This genetic information can …
applications of analyzing circulating tumor DNA (ctDNA). This genetic information can …
Molecular residual disease and adjuvant trial design in solid tumors
M Coakley, I Garcia-Murillas, NC Turner - Clinical Cancer Research, 2019 - AACR
Advances in diagnosis and treatment have resulted in a high rate of survival for many
patients with early-stage cancers. However, identifying who is at ongoing risk of relapse …
patients with early-stage cancers. However, identifying who is at ongoing risk of relapse …